Anticoagulation and bleeding: A pooled analysis of lung cancer trials of the National Cancer Institute of Canada Clinical Trials Group

8065 Background: Clinical trials may mandate LMW heparin (LMWH) rather than coumadin (C) for patients (pts) requiring anticoagulation; lower risks of bleeding and drug-drug interactions are reporte...